-
Research and development of new dual base editing tools to aid gene therapy
Time of Update: 2021-03-04
expression levels than cells that produced C-to-T base editing alone. Zhang Xiaohui, co-lead author of the paper and a doctoral student at the School of Life Sciences at East China University, explains that this means that the new dual-base editing system
-
Chinese scientists have discovered a new anti-aging target gene
Time of Update: 2021-03-04
scientists in China have revealed the principle of aging from the nervous system and genes, and discovered BAZ2B, a new anti-aging target gene, which provides a new theoretical basis for delaying brain aging. In the early hours of February
-
New progress has been made in the study of CNG gate-controlled molecular system
Time of Update: 2021-03-04
sensing. Zhang Yuebin, one of the authors of the paper and an associate researcher at Dalian Chemical Institute, told the China Science Journal, "The study of the gateing system of CNG ion channels is of great significance for understanding
-
How to optimize channel construction is a problem that the whole industry is considering at present
Time of Update: 2021-03-04
According to the Daily Economic News, the project, with a total investment of 44 million euros, will become AkzoNobel's fourth and largest decorative paint production base in China.
-
Cell Stem Cell Interpretation! Scientists have developed a new DNA therapy that promises to remove
Time of Update: 2021-03-04
used ION251 to remove myeloma stem cells without damaging healthy blood cells. 'These preclinical results are so striking that half of the microscope images we compared bone marrow samples between treated mice and untreated mice have been blank
-
Transfer into the home industry sub-rules Lawyer: should be in the agreement to indicate the material
Time of Update: 2021-03-04
that it was the same tile the next day, Ms. Gong went to the building materials market to negotiate with the merchants. Ms. Gong took a picture of the floor tiles in her home and compared them with the photos she had taken in the store before. At first
-
The wallpaper industry is changing again without tossing
Time of Update: 2021-03-04
in the wind of change blowing wallpaper market, many wallpaper enterprises think that only the enterprise itself "change blood", in order to adapt to the current wallpaper industry trends, in fact, not enough.
-
PPG Industries will use $1.5-2.5 billion in cash for acquisitions and share buybacks in 2015-2016
Time of Update: 2021-03-04
actively looking for suitable merger opportunities and will continue our share buyback policy. In 2015 and 2016, we plan to spend a total of $1.5-2.5 billion in cash on acquisitions and share buybacks in the hope of creating greater value for our
-
Koren's hanging up! Take 15 heavy-weight varieties, 36 over-rated varieties bright eyes, 11 new class 1 drugs, 41 new products on the road
Time of Update: 2021-03-04
Entering 2021, The Colum Pharmaceuticals product line continues to be happy news, 2 injections have been evaluated, 4 injections were approved at that time. just past 2020, Colum Pharmaceuticals has had a lot of gains: 15 varieties have been
-
High-value consumables new sharp Gligtai received 10 million levels of financing
Time of Update: 2021-03-04
This financing will continue to be used for the company's core product development.
-
Dr. Meng Pharmaceuticals new retail into the industry benchmark, into more than 2000 hospitals
Time of Update: 2021-03-04
To innovative new health technology to help smart hospitals move forward Dr. Meng is the leading mobile medical brand in China, covering mobile medical, pharmaceutical e-commerce, new retail, drugstore chains and other sectors.
-
Several articles focus on new achievements by scientists in the study of disease biomarkers!
Time of Update: 2021-03-04
with heart attack, blood-moderate or acute kidney injury may increase mortality, but researchers know very little about the physiological function of DPP3, and for this reason, they looked at the molecular mechanisms of DEP3 affecting RAS. : Sci
-
Howson landed in Hong Kong with 14 new products, which heavyweights will hit in 2019?
Time of Update: 2021-03-04
Pharmaceuticals has been in a difficult position, updating the prospectus again on April 11, 2019, referring to the introduction of a new investor Boyu Fund on January 25, 2019, with a strategic financing of $248 million, with a valuation of HK$65 billion
-
Increased concentration in the industry Well-known pharmaceutical companies are being sold
Time of Update: 2021-03-04
to the announcement, the core products of Ano Pharmaceuticals are oral solution of calcium glucafoate, vitamin C chewing tablets, ginseng stone granules, and its "Aono", "Kincin jin beggar" is a well-known brand of calcium supplementation for children. China
-
Soryuan Bio signed a licensing agreement to develop DB102 new adaptations
Time of Update: 2021-03-04
, , December 26, 2019 - Precision Medicine leader So yuan Bio today announced that it has signed a licensing agreement with Rumpus Therapeutics to develop DB102 for the treatment of specific adaptive disorders.
-
6 provinces and regions set up a new free trade test zone, the development of the pharmaceutical industry focus!
Time of Update: 2021-03-04
to the State Council for the record, by the Ministry of Commerce, the Ministry of Natural Resources responsible for the release. Shandong of functions. Jinan District focuses on the development of artificial
-
New anti-inflammatory drugs! AbbVie oral JAK1 inhibitor Rinvoq has been approved by the European Union to treat 2 new rheumatoids!
Time of Update: 2021-03-04
studies, Rinvoq reached the primary endpoint of the ACR20 response compared to a placebo. , 15 mg doses of Rinvoq and Adamo monoantigen showed non-poor effectiveness in treating the ACR20 response at week 12. patients treated with Rinvoq
-
New medicine for rare lung disease! Roche Esbriet (pyridone) is reviewed by the FDA as a priority
Time of Update: 2021-03-04
phase II clinical trial data show that Esbriet slowed the progression of the disease in UIDD patients at 24 weeks of treatment compared to a placebo.
-
The new health insurance catalog brings three opportunities for DTP pharmacies!
Time of Update: 2021-03-04
high-value drugs, such as innovative anti-cancer drugs or rare disease drugs, that are not on the health insurance list, and newly marketed drugs are opportunities that DTP pharmacy channels need to seize.
-
New drug for mild asthma! AstraZeneta has been approved ® the ® Drug Administration to treat mild asthma in adults and adolescents over 12 years of age!
Time of Update: 2021-03-04
are not timely and accurate diagnosis and treatment. , up to 30 to 40 percent of people with mild asthma are likely to have severe acute seizures. to effectively control symptoms and reduce the risk of acute onset, early anti-inflammatory
